$56.01
0[0.00%]
At close: May 15
$56.01
0[0.00%]
PreMarket: 4:00PM EDT
Immunocore Hldgs
(NASDAQ:IMCR)Immunocore Hldgs Stock (NASDAQ:IMCR), Quotes and News Summary
Immunocore Hldgs Stock (NASDAQ: IMCR) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 429.722K |
| Day Range | - - - |
| 52 Wk Range | 42.210 - 76.980 |
| Market Cap | $2.733B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 9.58% |
| Days to Cover | 9.64 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immunocore Hldgs (IMCR) stock?
You can purchase shares of Immunocore Hldgs (NASDAQ: IMCR) through any online brokerage.
Who are Immunocore Hldgs's (IMCR) competitors?
Other companies in Immunocore Hldgs’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and TG Therapeutics (NASDAQ:TGTX).
What is the target price for Immunocore Hldgs (IMCR) stock?
The latest price target for Immunocore Hldgs (NASDAQ: IMCR) was reported by Mizuho on Monday, May 13, 2024. The analyst firm set a price target for 88.00 expecting IMCR to rise to within 12 months (a possible 57.11% upside). 33 analyst firms have reported ratings in the last year.
Current Stock Price for Immunocore Hldgs (IMCR)?
The stock price for Immunocore Hldgs (NASDAQ: IMCR) is $56.01 last updated May 15, 2024 at 4:00 PM EDT.
Does Immunocore Hldgs (IMCR) pay a dividend?
There are no upcoming dividends for Immunocore Hldgs.
When is Immunocore Hldgs (NASDAQ:IMCR) reporting earnings?
Immunocore Hldgs’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Immunocore Hldgs (IMCR) going to split?
There is no upcoming split for Immunocore Hldgs.
What sector and industry does Immunocore Hldgs (IMCR) operate in?
Immunocore Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.